Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.01M Buy
1,233,885
+1,182,683
+2,310% +$4.47M ﹤0.01% 2128
2026
Q1
$187K Sell
51,202
-4,049
-7% -$15.3K ﹤0.01% 3541
2025
Q4
$163K Sell
55,251
-83,107
-60% -$228K ﹤0.01% 3679
2025
Q3
$335K Sell
138,358
-171,862
-55% -$551K ﹤0.01% 2038
2025
Q2
$1.02M Buy
310,220
+2,051
+0.7% +$7.43K ﹤0.01% 1553
2025
Q1
$1.19M Buy
308,169
+127,269
+70% +$529K ﹤0.01% 1392
2024
Q4
$698K Buy
180,900
+4,100
+2% +$22.6K ﹤0.01% 1570
2024
Q3
$1.3M Buy
176,800
+135,600
+329% +$889K ﹤0.01% 1333
2024
Q2
$266K Buy
41,200
+15,600
+61% +$124K ﹤0.01% 1564
2024
Q1
$270K Buy
+25,600
New +$209K ﹤0.01% 1818
2018
Q3
Sell
-150,000
Closed -$3.9M 1004
2018
Q2
$3.9M Buy
+150,000
New +$3.87M 0.02% 660

Other funds holding BAK

Steven Cohen's BAK Position: Q2 2026 in Review

Steven Cohen increased its Braskem (BAK) stake by 2,310% in Q2 2026, buying an estimated $4.47M and bringing the position to 1,233,885 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2128.

Steven Cohen first reported a position in BAK in Q2 2018 and has held it in 11 quarters since. The position peaked at $3.9M in Q2 2018. 63 funds tracked by Wall St. Rank hold BAK as of Q2 2026.

  • Steven Cohen held 1,233,885 shares of Braskem worth $3.01M as of Q2 2026.
  • Steven Cohen bought 1,182,683 Braskem shares in Q2 2026, an estimated $4.47M.
  • Braskem made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2128 holding.
  • Steven Cohen first reported a position in Braskem in Q2 2018 and has held it in 11 quarters since.
  • Steven Cohen's Braskem position peaked at $3.9M in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Braskem as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.